Authors: FURLONG T STORB R ANASETTI C APPELBAUM F DEEG HJ DONEY K MARTIN P SULLIVAN KM WITHERSPOON R NASH RA

Citation: T. Furlong et al., CONVERSION TO FK506 FOR CYCLOSPORINE (CSP)-RESISTANT ACUTE GVHD OR CSP-ASSOCIATED TOXICITY, Blood, 90(10), 1997, pp. 458-458

Authors: NASH RA FURLONG T STORB R ANASETTI C APPELBAUM FR DEEG HJ DONEY K MARTIN P WITHERSPOON R SULLIVAN KM

Citation: Ra. Nash et al., MYCOPHENOLATE MOFETIL (MMF) AS SALVAGE TREATMENT FOR GRAFT-VERSUS-HOST DISEASE (GVHD) AFTER ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTATION (HSCT) - SAFETY ANALYSIS, Blood, 90(10), 1997, pp. 459-459

Authors: NASH RA PINEIRO LA STORB R DEEG HJ FITZSIMMONS WE FURLONG T HANSEN JA GOOLEY T MAHER RM MARTIN P MCSWEENEY PA SULLIVAN KM ANASETTI C FAY JW

Citation: Ra. Nash et al., FK506 IN COMBINATION WITH METHOTREXATE FOR THE PREVENTION OF GRAFT-VERSUS-HOST DISEASE AFTER MARROW TRANSPLANTATION FROM MATCHED UNRELATED DONORS, Blood, 88(9), 1996, pp. 3634-3641

Authors: NASH RA ETZIONI R STORB R FURLONG T GOOLEY T ANASETTI C APPELBAUM FR DONEY K MARTIN P SLATTERY J SULLIVAN K VANDERJAGT R WITHERSPOON R JUSKO WJ ZAGER RA DEEG HJ

Citation: Ra. Nash et al., TACROLIMUS (FK506) ALONE OR IN COMBINATION WITH METHOTREXATE OR METHYLPREDNISOLONE FOR THE PREVENTION OF ACUTE GRAFT-VERSUS-HOST DISEASE AFTER MARROW TRANSPLANTATION FROM HLA-MATCHED SIBLINGS - A SINGLE-CENTERSTUDY, Blood, 85(12), 1995, pp. 3746-3753

Authors: NASH RA MCSWEENEY PA STORB R GOOLEY T FURLONG T APPELBAUM F DEEG HJ DONEY K MARTIN P SULLIVAN K WITHERSPOON R ZAGER RA HANSEN JA ANASETTI C

Citation: Ra. Nash et al., FK506 IN COMBINATION WITH METHOTREXATE (MTX) FOR THE PREVENTION OF GRAFT-VERSUS-HOST DISEASE (GVHD) AFTER MARROW TRANSPLANTATION FROM PHENOTYPICALLY HLA-IDENTICAL UNRELATED DONORS, Blood, 84(10), 1994, pp. 10000394-10000394

Authors: NASH RA DEEG HJ STORB R ETZIONI R FURLONG T GOOLEY T ANASETTI C APPELBAUM F DONEY K MARTIN P SULLIVAN K WITHERSPOON R ZAGER RA

Citation: Ra. Nash et al., FK506 ALONE OR IN COMBINATION WITH METHOTREXATE (MTX) OR METHYLPREDNISOLONE (MP) FOR THE PREVENTION OF GRAFT-VS-HOST DISEASE (GVHD) AFTER MARROW TRANSPLANTATION FROM HLA-MATCHED SIBLINGS - A SINGLE-CENTER STUDY, Blood, 82(10), 1993, pp. 10000421-10000421